OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $1.66 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share Today's Range$1.62▼$1.6950-Day Range$1.38▼$2.0052-Week Range$1.06▼$2.66Volume1.53 million shsAverage Volume780,125 shsMarket Capitalization$810.31 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Cresco Labs alerts: Email Address Cresco Labs MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside50.6% Upside$2.50 Price TargetShort InterestHealthy0.36% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.85 out of 5 stars 3.5 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 3 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.36% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently decreased by 5.52%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 1.9 News and Social Media Coverage News SentimentCresco Labs has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cresco Labs this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for CRLBF on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -88% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” About Cresco Labs Stock (OTCMKTS:CRLBF)Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesSeptember 12 at 12:58 PM | nasdaq.comCresco Labs Chief Financial Officer Dennis Olis To RetireSeptember 12 at 7:57 AM | finance.yahoo.comCresco Labs Announces Dennis Olis to Retire as Chief Financial OfficerSeptember 15, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.September 9, 2024 | benzinga.comIs Cresco Labs An Overlooked Cannabis Stock? Market Potential In Ohio, Florida & Pennsylvania Promise OpportunityAugust 29, 2024 | seekingalpha.comCresco Labs Remains Strong Amidst Rescheduling Uncertainties (Hold)August 19, 2024 | nz.finance.yahoo.comCresco Labs Inc (6CQ.BE)August 14, 2024 | finance.yahoo.comNational Leading Vape Brand, Bloom, Partners With Cresco Labs to Launch Products in FloridaAugust 13, 2024 | proactiveinvestors.comCannabis MSOs embrace new markets, streamline operations in Q2September 15, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.August 13, 2024 | markets.businessinsider.comHaywood Reaffirms Their Buy Rating on Cresco Labs (CRLBF)August 8, 2024 | seekingalpha.comCresco Labs Inc. (CRLBF) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | finance.yahoo.comCresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial ResultsAugust 8, 2024 | markets.businessinsider.comCresco Labs earnings: here's what to expectAugust 6, 2024 | finance.yahoo.comCresco Labs Launches Adult-Use Cannabis Distribution and Retail Sales in OhioJuly 30, 2024 | bizjournals.comCresco Labs in Yellow Springs receives dual use cannabis licenseJuly 25, 2024 | msn.comCresco Labs in Yellow Springs receives operational license for recreational weedJuly 9, 2024 | investorplace.com7 Pot Stock Pioneers Poised for High ReturnsMay 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cresco Labs (OtherCRLBF) and Immunocore Holdings (IMCR)See More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+50.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-23.07% Pretax Margin-17.58% Return on Equity-17.03% Return on Assets-5.13% Debt Debt-to-Equity Ratio1.76 Current Ratio2.00 Quick Ratio1.30 Sales & Book Value Annual Sales$770.89 million Price / Sales1.05 Cash Flow$0.05 per share Price / Cash Flow32.63 Book Value$1.24 per share Price / Book1.34Miscellaneous Outstanding Shares488,140,000Free FloatN/AMarket Cap$810.31 million OptionableNot Optionable Beta1.85 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Charles Bachtell (Age 45)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 49)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 61)Chief Financial Officer Comp: $622.85kMr. Gregory Butler (Age 43)President & Chief Transformation Officer Mr. Ty Gent (Age 65)Chief Operating Officer Mr. Zach Marburger (Age 39)Chief Information Officer Ms. Megan KulickSenior Vice President of Investor RelationsMr. John Schetz (Age 46)General Counsel Mr. Jason Erkes (Age 53)Chief Communications Officer Ms. Angie Demchenko (Age 43)Chief People Officer More ExecutivesKey CompetitorsXenon PharmaceuticalsNASDAQ:XENERhythm PharmaceuticalsNASDAQ:RYTMHUTCHMEDNASDAQ:HCMIovance BiotherapeuticsNASDAQ:IOVAMorphoSysNASDAQ:MORView All Competitors CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $1.3558 on January 1st, 2024. Since then, CRLBF shares have increased by 22.4% and is now trading at $1.66. View the best growth stocks for 2024 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) posted its earnings results on Thursday, August, 8th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.15. The company had revenue of $184.36 million for the quarter, compared to analyst estimates of $184.26 million. Cresco Labs had a negative net margin of 23.07% and a negative trailing twelve-month return on equity of 17.03%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRLBF) was last updated on 9/15/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.